Gerresheimer upbeat amid earnings decline

Comments Email
Photo by Gerresheimer's Twitter page

German manufacturer of primary packaging for medical and pharmaceutical industries Gerresheimer AG has reported a slight drop in earnings despite increased sales in 2018. 

The company posted a 4.3% year-on-year increase in sales at €1.4 billion last year, helped by a strong fourth quarter and a “clear recovery” in the US. 

“The business with injection vials, ampoules and cartridges in the US saw a clear recovery in 2018,” said the company in its annual financial results 14 Feb. 

Adjusted EBITDA (earnings) at constant exchange rates stood at €308.0m, just under 1% lower than €310.8m in 2017. 

The lower earnings rate was attributed to one-off effects, including the setting up of an advanced technology division to develop smart drug delivery systems. 

In addition to the establishment of the new division, 2018 also saw a plant closure in Kuessnacht, Switzerland, and further reorganisation measures in the medical plastics systems unit. The plant closure, said Gerresheimer, was due to losing a contract for inhalers in Europe. 

In the US, however, the inhaler production business performed “very well”, said Gerresheimer, adding that the performance led to a “follow-up” order for its plant in Horsovsky Tyn, Czech Republic. 

In July 2018, Gerresheimer acquired Swiss-based Sensile Medical, specialised in micro pump technology, which it has incorporated into the advanced technologies division. 

“We have a sound plan for 2019, which entails building up further growth impetus in the medium and long term,” said Dietmar Siemssen, who took the helm at Gerresheimer in November last year. 


Select from the list below to subscribe to customized Plastics News Europe e-mail news alerts. Check the options you wish to receive.